论文部分内容阅读
目的 :研究乌司他丁联合奥曲肽治疗重症急性胰腺炎的临床效果。方法 :选择2015年2月-2016年2月,医院收治的重症急性胰腺炎患者104例,随机分为对照组和观察组,每组患者52例。对照组患者在常规治疗基础上,加用乌司他丁进行治疗,观察组患者在常规治疗基础上,加用乌司他丁联合奥曲肽进行治疗。治疗后,对比两组患者的治疗效果,同时对比两组患者的相关临床指标。结果 :治疗后,观察组患者的治疗总有效率为94.23%,高于对照组患者的71.15%(P<0.05)。治疗后,观察组患者住院时间、症状缓解时间、淀粉酶恢复时间均少于对照组患者(P<0.05)。结论 :使用乌司他丁联合奥曲肽,对重症急性胰腺炎进行治疗,能够取得理想的治疗效果。
Objective: To study the clinical effect of ulinastatin combined with octreotide in the treatment of severe acute pancreatitis. Methods: From February 2015 to February 2016, 104 patients with severe acute pancreatitis admitted to the hospital were randomly divided into control group and observation group, with 52 patients in each group. The patients in the control group were treated with ulinastatin on the basis of routine treatment. The patients in the observation group were treated with ulinastatin and octreotide on the basis of routine treatment. After treatment, the two groups of patients were compared for the treatment effect, while comparing the two groups of patients with clinical indicators. Results: After treatment, the total effective rate of the observation group was 94.23%, which was higher than 71.15% of the control group (P <0.05). After treatment, the hospitalization time, symptom relief time and amylase recovery time in observation group were less than those in control group (P <0.05). Conclusion: Ulinastatin combined with octreotide, for treatment of severe acute pancreatitis, can achieve the desired therapeutic effect.